For decades, the biotech company Genentech has carved out a reputation in the industry as a scientist’s paradise, a place where researchers have developed new therapies in-house and published ...

HYDERABAD, Aug 27 (Reuters) - India's Bharat Biotech said on Tuesday its oral cholera vaccine cleared a late-stage trial and that it plans a global launch, aiming to make up to 200 million doses a ...

Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox. Good morning! Today, we discuss the woman who spearheaded progress in ...

These companies are nearly in the sweet spot of risk versus reward in biotech. Many investors rightfully identify biotech stocks as being riskier than average, and those stocks certainly have a ...

BioMarin Pharmaceutical, a San Rafael biotech company known for treating extremely rare diseases, said Wednesday it’s laying off 225 workers, most of whom live and work in California.

Why should investors care about this program and this biotech at this time? That's because it has also already released positive data at the 2024 European Hematology Association [EHA] conference.

Tome Biosciences, Inc., a Watertown-based biotech company, will lay off 131 employees beginning Nov. 1, state filings show. The biotech company, which was founded in 2021, focuses on “delivering ...

Dhaval Patel, M.D., Ph.D. (Sana Biotechnology) Dhaval Patel, M.D., Ph.D., is joining cell engineering biotech Sana Biotechnology as its first chief scientific officer following his tenure in the s ...

The Union Cabinet on Saturday (August 24, 2024) cleared a proposal to bolster biotechnology-based manufacturing, called BioE3 (Biotechnology for Economy, Environment and Employment) Policy for ...

Alzheimer’s disease research and drug development is evolving at a rapid pace. Decades of research has led to the approval of the first disease-modifying drugs and new pathological discoveries.

Zydus Lifesciences Ltd through its wholly-owned subsidiary has signed an agreement to acquire a 50 per cent stake in Sterling Biotech Ltd (SBL) from Perfect Day Inc., a Temasek portfolio company.